1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Drug Discovery Technologies Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Biochips 1.2.3 High throughput screening 1.2.4 Pharmacogenomics 1.2.5 Genomics 1.2.6 Bioanalytical instruments 1.2.7 Bioinformatics 1.2.8 Nanotechnology 1.2.9 Others 1.3 Market by Application 1.3.1 Global Drug Discovery Technologies Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 Pharmaceutical Companies 1.3.3 Research Institutes 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Drug Discovery Technologies Market Size (2017-2028) 2.2 Drug Discovery Technologies Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global Drug Discovery Technologies Market Size by Region (2017-2022) 2.4 Global Drug Discovery Technologies Market Size Forecast by Region (2023-2028) 2.5 Global Top Drug Discovery Technologies Countries Ranking by Market Size 3 Drug Discovery Technologies Competitive by Company 3.1 Global Drug Discovery Technologies Revenue by Players 3.1.1 Global Drug Discovery Technologies Revenue by Players (2017-2022) 3.1.2 Global Drug Discovery Technologies Market Share by Players (2017-2022) 3.2 Global Drug Discovery Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by Drug Discovery Technologies Revenue 3.4 Global Drug Discovery Technologies Market Concentration Ratio 3.4.1 Global Drug Discovery Technologies Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery Technologies Revenue in 2021 3.5 Global Drug Discovery Technologies Key Players Head office and Area Served 3.6 Key Players Drug Discovery Technologies Product Solution and Service 3.7 Date of Enter into Drug Discovery Technologies Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Drug Discovery Technologies Breakdown Data by Type 4.1 Global Drug Discovery Technologies Historic Revenue by Type (2017-2022) 4.2 Global Drug Discovery Technologies Forecasted Revenue by Type (2023-2028) 5 Global Drug Discovery Technologies Breakdown Data by Application 5.1 Global Drug Discovery Technologies Historic Market Size by Application (2017-2022) 5.2 Global Drug Discovery Technologies Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Drug Discovery Technologies Revenue by Company (2020-2022) 6.2 North America Drug Discovery Technologies Revenue by Type (2017-2028) 6.3 North America Drug Discovery Technologies Revenue by Application (2017-2028) 6.4 North America Drug Discovery Technologies Revenue by Country (2017-2028) 6.4.1 U.S. 6.4.2 Canada 7 Europe 7.1 Europe Drug Discovery Technologies Revenue by Company (2020-2022) 7.2 Europe Drug Discovery Technologies Revenue by Type (2017-2028) 7.3 Europe Drug Discovery Technologies Revenue by Application (2017-2028) 7.4 Europe Drug Discovery Technologies Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific Drug Discovery Technologies Revenue by Company (2020-2022) 8.2 Asia Pacific Drug Discovery Technologies Revenue by Type (2017-2028) 8.3 Asia Pacific Drug Discovery Technologies Revenue by Application (2017-2028) 8.4 Asia Pacific Drug Discovery Technologies Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 8.4.10 Philippines 8.4.11 Vietnam 9 Latin America 9.1 Latin America Drug Discovery Technologies Revenue by Company (2020-2022) 9.2 Latin America Drug Discovery Technologies Revenue by Type (2017-2028) 9.3 Latin America Drug Discovery Technologies Revenue by Application (2017-2028) 9.4 Latin America Drug Discovery Technologies Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Drug Discovery Technologies Revenue by Company (2020-2022) 10.2 Middle East and Africa Drug Discovery Technologies Revenue by Type (2017-2028) 10.3 Middle East and Africa Drug Discovery Technologies Revenue by Application (2017-2028) 10.4 Middle East and Africa Drug Discovery Technologies Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 U.A.E 11 Company Profiles 11.1 Agilent 11.1.1 Agilent Company Details 11.1.2 Agilent Business Overview 11.1.3 Agilent Drug Discovery Technologies Products and Services 11.1.4 Agilent Drug Discovery Technologies Revenue in Drug Discovery Technologies Business (2017-2022) 11.1.5 Agilent Drug Discovery Technologies SWOT Analysis 11.1.6 Agilent Recent Developments 11.2 GE Healthcare 11.2.1 GE Healthcare Company Details 11.2.2 GE Healthcare Business Overview 11.2.3 GE Healthcare Drug Discovery Technologies Products and Services 11.2.4 GE Healthcare Drug Discovery Technologies Revenue in Drug Discovery Technologies Business (2017-2022) 11.2.5 GE Healthcare Drug Discovery Technologies SWOT Analysis 11.2.6 GE Healthcare Recent Developments 11.3 Albany Molecular Research Inc. 11.3.1 Albany Molecular Research Inc. Company Details 11.3.2 Albany Molecular Research Inc. Business Overview 11.3.3 Albany Molecular Research Inc. Drug Discovery Technologies Products and Services 11.3.4 Albany Molecular Research Inc. Drug Discovery Technologies Revenue in Drug Discovery Technologies Business (2017-2022) 11.3.5 Albany Molecular Research Inc. Drug Discovery Technologies SWOT Analysis 11.3.6 Albany Molecular Research Inc. Recent Developments 11.4 Affymetrix 11.4.1 Affymetrix Company Details 11.4.2 Affymetrix Business Overview 11.4.3 Affymetrix Drug Discovery Technologies Products and Services 11.4.4 Affymetrix Drug Discovery Technologies Revenue in Drug Discovery Technologies Business (2017-2022) 11.4.5 Affymetrix Drug Discovery Technologies SWOT Analysis 11.4.6 Affymetrix Recent Developments 11.5 Bayer Healthcare 11.5.1 Bayer Healthcare Company Details 11.5.2 Bayer Healthcare Business Overview 11.5.3 Bayer Healthcare Drug Discovery Technologies Products and Services 11.5.4 Bayer Healthcare Drug Discovery Technologies Revenue in Drug Discovery Technologies Business (2017-2022) 11.5.5 Bayer Healthcare Drug Discovery Technologies SWOT Analysis 11.5.6 Bayer Healthcare Recent Developments 11.6 Novartis 11.6.1 Novartis Company Details 11.6.2 Novartis Business Overview 11.6.3 Novartis Drug Discovery Technologies Products and Services 11.6.4 Novartis Drug Discovery Technologies Revenue in Drug Discovery Technologies Business (2017-2022) 11.6.5 Novartis Drug Discovery Technologies SWOT Analysis 11.6.6 Novartis Recent Developments 11.7 AstraZeneca 11.7.1 AstraZeneca Company Details 11.7.2 AstraZeneca Business Overview 11.7.3 AstraZeneca Drug Discovery Technologies Products and Services 11.7.4 AstraZeneca Drug Discovery Technologies Revenue in Drug Discovery Technologies Business (2017-2022) 11.7.5 AstraZeneca Drug Discovery Technologies SWOT Analysis 11.7.6 AstraZeneca Recent Developments 12 Drug Discovery Technologies Market Dynamics 12.1 Drug Discovery Technologies Market Trends 12.2 Drug Discovery Technologies Market Drivers 12.3 Drug Discovery Technologies Market Challenges 12.4 Drug Discovery Technologies Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details

List of Tables Table 1. Global Drug Discovery Technologies Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Biochips Table 3. Key Players of High throughput screening Table 4. Key Players of Pharmacogenomics Table 5. Key Players of Genomics Table 6. Key Players of Bioanalytical instruments Table 7. Key Players of Bioinformatics Table 8. Key Players of Nanotechnology Table 9. Key Players of Others Table 10. Global Drug Discovery Technologies Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 11. Global Drug Discovery Technologies Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 12. Global Drug Discovery Technologies Revenue by Region (2017-2022) & (US$ Million) Table 13. Global Drug Discovery Technologies Revenue Market Share by Region (2017-2022) Table 14. Global Drug Discovery Technologies Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Drug Discovery Technologies Market Share by Players (2017-2022) Table 16. Global Top Drug Discovery Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery Technologies as of 2021) Table 17. Ranking of Global Top Drug Discovery Technologies Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Drug Discovery Technologies Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Drug Discovery Technologies Product Solution and Service Table 21. Date of Key Manufacturers Enter into Drug Discovery Technologies Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Drug Discovery Technologies Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Drug Discovery Technologies Revenue Market Share by Type (2017-2022) Table 25. Global Drug Discovery Technologies Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Drug Discovery Technologies Revenue Market Share by Type (2023-2028) Table 27. Global Drug Discovery Technologies Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Drug Discovery Technologies Revenue Market Share by Application (2017-2022) Table 29. Global Drug Discovery Technologies Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Drug Discovery Technologies Revenue Market Share by Application (2023-2028) Table 31. North America Drug Discovery Technologies Revenue by Company (2020-2022) & (US$ Million) Table 32. North America Drug Discovery Technologies Revenue by Type (2017-2022) & (US$ Million) Table 33. North America Drug Discovery Technologies Revenue by Type (2023-2028) & (US$ Million) Table 34. North America Drug Discovery Technologies Revenue by Application (2017-2022) & (US$ Million) Table 35. North America Drug Discovery Technologies Revenue by Application (2023-2028) & (US$ Million) Table 36. North America Drug Discovery Technologies Revenue by Country (2017-2022) & (US$ Million) Table 37. North America Drug Discovery Technologies Revenue by Country (2023-2028) & (US$ Million) Table 38. Europe Drug Discovery Technologies Revenue by Company (2020-2022) & (US$ Million) Table 39. Europe Drug Discovery Technologies Revenue by Type (2017-2022) & (US$ Million) Table 40. Europe Drug Discovery Technologies Revenue by Type (2023-2028) & (US$ Million) Table 41. Europe Drug Discovery Technologies Revenue by Application (2017-2022) & (US$ Million) Table 42. Europe Drug Discovery Technologies Revenue by Application (2023-2028) & (US$ Million) Table 43. Europe Drug Discovery Technologies Revenue by Country (2017-2022) & (US$ Million) Table 44. Europe Drug Discovery Technologies Revenue by Country (2023-2028) & (US$ Million) Table 45. Asia Pacific Drug Discovery Technologies Revenue by Company (2020-2022) & (US$ Million) Table 46. Asia Pacific Drug Discovery Technologies Revenue by Type (2017-2022) & (US$ Million) Table 47. Asia Pacific Drug Discovery Technologies Revenue by Type (2023-2028) & (US$ Million) Table 48. Asia Pacific Drug Discovery Technologies Revenue by Application (2017-2022) & (US$ Million) Table 49. Asia Pacific Drug Discovery Technologies Revenue by Application (2023-2028) & (US$ Million) Table 50. Asia Pacific Drug Discovery Technologies Revenue by Region (2017-2022) & (US$ Million) Table 51. Asia Pacific Drug Discovery Technologies Revenue by Region (2023-2028) & (US$ Million) Table 52. Latin America Drug Discovery Technologies Revenue by Company (2020-2022) & (US$ Million) Table 53. Latin America Drug Discovery Technologies Revenue by Type (2017-2022) & (US$ Million) Table 54. Latin America Drug Discovery Technologies Revenue by Type (2023-2028) & (US$ Million) Table 55. Latin America Drug Discovery Technologies Revenue by Application (2017-2022) & (US$ Million) Table 56. Latin America Drug Discovery Technologies Revenue by Application (2023-2028) & (US$ Million) Table 57. Latin America Drug Discovery Technologies Revenue by Country (2017-2022) & (US$ Million) Table 58. Latin America Drug Discovery Technologies Revenue by Country (2023-2028) & (US$ Million) Table 59. Middle East and Africa Drug Discovery Technologies Revenue by Company (2020-2022) & (US$ Million) Table 60. Middle East and Africa Drug Discovery Technologies Revenue by Type (2017-2022) & (US$ Million) Table 61. Middle East and Africa Drug Discovery Technologies Revenue by Type (2023-2028) & (US$ Million) Table 62. Middle East and Africa Drug Discovery Technologies Revenue by Application (2017-2022) & (US$ Million) Table 63. Middle East and Africa Drug Discovery Technologies Revenue by Application (2023-2028) & (US$ Million) Table 64. Middle East and Africa Drug Discovery Technologies Revenue by Country (2017-2022) & (US$ Million) Table 65. Middle East and Africa Drug Discovery Technologies Revenue by Country (2023-2028) & (US$ Million) Table 66. Agilent Company Details Table 67. Agilent Business Overview Table 68. Agilent Drug Discovery Technologies Product and Services Table 69. Agilent Drug Discovery Technologies Revenue in Drug Discovery Technologies Business (2017-2022) & (US$ Million) Table 70. Agilent Drug Discovery Technologies SWOT Analysis Table 71. Agilent Recent Developments Table 72. GE Healthcare Company Details Table 73. GE Healthcare Business Overview Table 74. GE Healthcare Drug Discovery Technologies Product and Services Table 75. GE Healthcare Drug Discovery Technologies Revenue in Drug Discovery Technologies Business (2017-2022) & (US$ Million) Table 76. GE Healthcare Drug Discovery Technologies SWOT Analysis Table 77. GE Healthcare Recent Developments Table 78. Albany Molecular Research Inc. Company Details Table 79. Albany Molecular Research Inc. Business Overview Table 80. Albany Molecular Research Inc. Drug Discovery Technologies Product and Services Table 81. Albany Molecular Research Inc. Drug Discovery Technologies Revenue in Drug Discovery Technologies Business (2017-2022) & (US$ Million) Table 82. Albany Molecular Research Inc. Drug Discovery Technologies SWOT Analysis Table 83. Albany Molecular Research Inc. Recent Developments Table 84. Affymetrix Company Details Table 85. Affymetrix Business Overview Table 86. Affymetrix Drug Discovery Technologies Product and Services Table 87. Affymetrix Drug Discovery Technologies Revenue in Drug Discovery Technologies Business (2017-2022) & (US$ Million) Table 88. Affymetrix Drug Discovery Technologies SWOT Analysis Table 89. Affymetrix Recent Developments Table 90. Bayer Healthcare Company Details Table 91. Bayer Healthcare Business Overview Table 92. Bayer Healthcare Drug Discovery Technologies Product and Services Table 93. Bayer Healthcare Drug Discovery Technologies Revenue in Drug Discovery Technologies Business (2017-2022) & (US$ Million) Table 94. Bayer Healthcare Drug Discovery Technologies SWOT Analysis Table 95. Bayer Healthcare Recent Developments Table 96. Novartis Company Details Table 97. Novartis Business Overview Table 98. Novartis Drug Discovery Technologies Product and Services Table 99. Novartis Drug Discovery Technologies Revenue in Drug Discovery Technologies Business (2017-2022) & (US$ Million) Table 100. Novartis Drug Discovery Technologies SWOT Analysis Table 101. Novartis Recent Developments Table 102. AstraZeneca Company Details Table 103. AstraZeneca Business Overview Table 104. AstraZeneca Drug Discovery Technologies Product and Services Table 105. AstraZeneca Drug Discovery Technologies Revenue in Drug Discovery Technologies Business (2017-2022) & (US$ Million) Table 106. AstraZeneca Drug Discovery Technologies SWOT Analysis Table 107. AstraZeneca Recent Developments Table 108. Drug Discovery Technologies Market Trends Table 109. Drug Discovery Technologies Market Drivers Table 110. Drug Discovery Technologies Market Challenges Table 111. Drug Discovery Technologies Market Restraints Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Global Drug Discovery Technologies Sales Market Share by Type: 2021 VS 2028 Figure 2. Biochips Features Figure 3. High throughput screening Features Figure 4. Pharmacogenomics Features Figure 5. Genomics Features Figure 6. Bioanalytical instruments Features Figure 7. Bioinformatics Features Figure 8. Nanotechnology Features Figure 9. Others Features Figure 10. Global Drug Discovery Technologies Sales Market Share by Application: 2021 VS 2028 Figure 11. Pharmaceutical Companies Case Studies Figure 12. Research Institutes Case Studies Figure 13. Others Case Studies Figure 14. Drug Discovery Technologies Report Years Considered Figure 15. Global Drug Discovery Technologies Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 16. Global Drug Discovery Technologies Market Size 2017-2028 (US$ Million) Figure 17. Global Drug Discovery Technologies Market Size Market Share by Region: 2021 VS 2028 Figure 18. Global Drug Discovery Technologies Revenue Market Share by Region in 2017 VS 2022 Figure 19. Global Top 10 Drug Discovery Technologies Countries Ranking by Market Size (US$ Million) in 2021 Figure 20. Global Drug Discovery Technologies Market Share by Players in 2021 Figure 21. Global Top Drug Discovery Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery Technologies as of 2021) Figure 22. The Top 10 and 5 Players Market Share by Drug Discovery Technologies Revenue in 2021 Figure 23. North America Drug Discovery Technologies Revenue Market Share by Company in 2021 Figure 24. North America Drug Discovery Technologies Revenue Market Share by Type (2017-2028) Figure 25. North America Drug Discovery Technologies Revenue Market Share by Application (2017-2028) Figure 26. North America Drug Discovery Technologies Revenue Share by Country (2017-2028) Figure 27. U.S. Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 28. Canada Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 29. Europe Drug Discovery Technologies Revenue Market Share by Company in 2021 Figure 30. Europe Drug Discovery Technologies Revenue Market Share by Type (2017-2028) Figure 31. Europe Drug Discovery Technologies Revenue Market Share by Application (2017-2028) Figure 32. Europe Drug Discovery Technologies Revenue Share by Country (2017-2028) Figure 33. Germany Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 34. France Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 35. U.K. Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 36. Italy Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 37. Russia Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 38. Asia Pacific Drug Discovery Technologies Revenue Market Share by Company in 2021 Figure 39. Asia Pacific Drug Discovery Technologies Revenue Market Share by Type (2017-2028) Figure 40. Asia Pacific Drug Discovery Technologies Revenue Market Share by Application (2017-2028) Figure 41. Asia Pacific Drug Discovery Technologies Revenue Share by Region (2017-2028) Figure 42. China Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 43. Japan Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 44. South Korea Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 45. India Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 46. Australia Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 47. Taiwan Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 48. Indonesia Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 49. Thailand Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 50. Malaysia Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 51. Philippines Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 52. Vietnam Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 53. Latin America Drug Discovery Technologies Revenue Market Share by Company in 2021 Figure 54. Latin America Drug Discovery Technologies Revenue Market Share by Type (2017-2028) Figure 55. Latin America Drug Discovery Technologies Revenue Market Share by Application (2017-2028) Figure 56. Latin America Drug Discovery Technologies Revenue Share by Country (2017-2028) Figure 57. Mexico Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 58. Brazil Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 59. Argentina Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 60. Middle East and Africa Drug Discovery Technologies Revenue Market Share by Company in 2021 Figure 61. Middle East and Africa Drug Discovery Technologies Revenue Market Share by Type (2017-2028) Figure 62. Middle East and Africa Drug Discovery Technologies Revenue Market Share by Application (2017-2028) Figure 63. Middle East and Africa Drug Discovery Technologies Revenue Share by Country (2017-2028) Figure 64. Turkey Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 65. Saudi Arabia Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 66. U.A.E Drug Discovery Technologies Revenue (2017-2028) & (US$ Million) Figure 67. Agilent Revenue Growth Rate in Drug Discovery Technologies Business (2017-2022) Figure 68. GE Healthcare Revenue Growth Rate in Drug Discovery Technologies Business (2017-2022) Figure 69. Albany Molecular Research Inc. Revenue Growth Rate in Drug Discovery Technologies Business (2017-2022) Figure 70. Affymetrix Revenue Growth Rate in Drug Discovery Technologies Business (2017-2022) Figure 71. Bayer Healthcare Revenue Growth Rate in Drug Discovery Technologies Business (2017-2022) Figure 72. Novartis Revenue Growth Rate in Drug Discovery Technologies Business (2017-2022) Figure 73. AstraZeneca Revenue Growth Rate in Drug Discovery Technologies Business (2017-2022) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

Agilent GE Healthcare Albany Molecular Research Inc. Affymetrix Bayer Healthcare Novartis AstraZeneca